Literature DB >> 9734950

Granulocytosis causing sickle-cell crisis.

M Abboud, J Laver, C A Blau.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9734950     DOI： 10.1016/S0140-6736(05)60614-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

2.  Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.

Authors:  Vicky Chaar; Julien Picot; Olivier Renaud; Pablo Bartolucci; Ruben Nzouakou; Dora Bachir; Frédéric Galactéros; Yves Colin; Caroline Le Van Kim; Wassim El Nemer
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

3.  Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

Authors:  Evangelia Yannaki; Thalia Papayannopoulou; Erica Jonlin; Fani Zervou; Garyfalia Karponi; Angeliki Xagorari; Pamela Becker; Nikoleta Psatha; Ioannis Batsis; Panayotis Kaloyannidis; Varvara Tahynopoulou; Varnavas Constantinou; Asimina Bouinta; Konstantia Kotta; Aglaia Athanassiadou; Achilles Anagnostopoulos; Athanasios Fassas; George Stamatoyannopoulos
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 4.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

5.  AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Authors:  André Larochelle; Allen Krouse; Mark Metzger; Donald Orlic; Robert E Donahue; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Peiman Hematti
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

6.  Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.

Authors:  Erica B Esrick; John P Manis; Heather Daley; Cristina Baricordi; Hélène Trébéden-Negre; Francis J Pierciey; Myriam Armant; Sarah Nikiforow; Matthew M Heeney; Wendy B London; Luca Biasco; Mohammed Asmal; David A Williams; Alessandra Biffi
Journal:  Blood Adv       Date:  2018-10-09

Review 7.  Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.

Authors:  Valentina Ghiaccio; Maxwell Chappell; Stefano Rivella; Laura Breda
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

8.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

10.  Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury.

Authors:  Andrés Hidalgo; Jungshan Chang; Jung-Eun Jang; Anna J Peired; Elaine Y Chiang; Paul S Frenette
Journal:  Nat Med       Date:  2009-03-22       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.